All Stories

  1. The biology of Mur ligases as an antibacterial target

    Article • Molecular Microbiology, September 2014, Wiley

    Dr Catherine Paradis-Bleau

  2. A Genome-Wide Screen for Bacterial Envelope Biogenesis Mutants Identifies a Novel Factor Involved in Cell Wall Precursor Metabolism

    Article • PLoS Genetics, January 2014, PLOS

    Dr Catherine Paradis-Bleau

  3. Lipoprotein Cofactors Located in the Outer Membrane Activate Bacterial Cell Wall Polymerases

    Article • Cell, December 2010, Elsevier

    Dr Catherine Paradis-Bleau

  4. Caveolin-1 Modifies the Immunity to Pseudomonas aeruginosa

    Article • The Journal of Immunology, November 2009, The American Association of Immunologists

    Dr Catherine Paradis-Bleau

  5. Biophysical studies of the interactions between the phage ϕKZ gp144 lytic transglycosylase and model membranes

    Article • European Biophysics Journal, August 2009, Springer Science + Business Media

    Dr Catherine Paradis-Bleau

  6. Pseudomonas aeruginosa MurE amide ligase: enzyme kinetics and peptide inhibitor

    Article • Biochemical Journal, July 2009, Portland Press Ltd.

    Dr Catherine Paradis-Bleau

  7. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa

    Article • Genome Research, October 2008, Cold Spring Harbor Laboratory Press

    Dr Catherine Paradis-Bleau, Morgan Langille

  8. Genome sequence of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa

    Article • Journal of Cystic Fibrosis, June 2008, Elsevier

    Dr Robert E Hancock, Dr Catherine Paradis-Bleau

  9. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis

    Article • Trends in Molecular Medicine, March 2008, Elsevier

    Dr Catherine Paradis-Bleau

  10. Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening

    Article • Bioorganic & Medicinal Chemistry, February 2008, Elsevier

    Dr Catherine Paradis-Bleau, prof mutasem taha

  11. Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF

    Article • BMC Biochemistry, January 2008, Springer Science + Business Media

    Dr Catherine Paradis-Bleau

  12. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials

    Article • Bioorganic & Medicinal Chemistry, February 2007, Elsevier

    Dr Catherine Paradis-Bleau

  13. Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage φKZ gp144 lytic transglycosylase

    Article • FEMS Microbiology Letters, January 2007, Oxford University Press (OUP)

    Dr Catherine Paradis-Bleau

  14. Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme

    Article • Peptides, July 2006, Elsevier

    Dr Catherine Paradis-Bleau

  15. Peptide inhibitors of the essential cell division protein FtsA

    Article • Protein Engineering Design and Selection, March 2005, Oxford University Press (OUP)

    Dr Catherine Paradis-Bleau

  16. Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials

    Article • Journal of Antimicrobial Chemotherapy, June 2004, Oxford University Press (OUP)

    Dr Catherine Paradis-Bleau